The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry–mass spectrometry
Open accessAbstract
The search for therapeutic agents that bind specifically to precursor protein conformations and inhibit amyloid assembly is an important challenge. Identifying such inhibitors is difficult because many protein precursors of aggregation are partially folded or intrinsically disordered, which rules out structure-based design. Furthermore, inhibitors can act by a variety of mechanisms, including specific or nonspecific binding, as well as colloidal inhibition. Here we report a high-throughput method based on ion mobility spectrometry–mass spectrometry (IMS–MS) that is capable of rapidly detecting small molecules that bind to amyloid precursors, identifying the interacting protein species and defining the mode of inhibition. Using this method we have classified a variety of small molecules that are potential inhibitors of human islet amyloid polypeptide (hIAPP) aggregation or amyloid-beta 1-40 aggregation as specific, nonspecific, colloidal or non-interacting. We also demonstrate the ability of IMS–MS to screen for inhibitory small molecules in a 96-well plate format and use this to discover a new inhibitor of hIAPP amyloid assembly. A method for rapidly screening small-molecule inhibitors of amyloid assembly has been developed. This method uses electrospray ionization–ion mobility spectrometry–mass spectrometry to detect and identify the type of inhibition. A screen of this nature could help in the discovery of therapeutics for numerous diseases associated with aberrant protein aggregation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D., Delaglio, F., & Tycko, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262663499 · Cited by 1,845
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,434
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., & Wanker, E. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910723107 · Cited by 1,011
Porat, Y., Abramowitz, A., & Gazit, E. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00318.x · Cited by 989
Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease
Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., Teter, B., Tran, T., Ubeda, O., Ashe, K. H., Frautschy, S. A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05709.2000 · Cited by 884
Applications of a travelling wave‐based radio‐frequency‐only stacked ring ion guide
Giles, K., Pringle, S. D., Worthington, K. R., Little, D., Wildgoose, J. L., & Bateman, R. H. (2004) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1641 · Cited by 727
Necula, M., Kayed, R., Milton, S., & Glabe, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608207200 · Cited by 680
Tenidis, K., Waldner, M., Bernhagen, J., Fischle, W., Bergmann, M., Weber, M., Merkle, M.-L., Voelter, W., Brunner, H., & Kapurniotu, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3422 · Cited by 426
Rational design of potent human transthyretin amyloid disease inhibitors.
Sacchettini, J. C., Klabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., & Kelly, J. W. (2000) · Nature Structural Biology · doi:10.1038/74082 · Cited by 379
Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils
Palhano, F. L., Lee, J., Grimster, N. P., & Kelly, J. W. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3115696 · Cited by 347
Choi, Y.-T., Jung, C.-H., Lee, S.-R., Bae, J.-H., Baek, W.-K., Suh, M.-H., Park, J., Park, C.-W., & Suh, S.-I. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01438-2 · Cited by 342
Is Congo Red an Amyloid-specific Dye?
Khurana, R., Uversky, V. N., Nielsen, L., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011499200 · Cited by 323
Sipe, J. D., Benson, M. D., Buxbaum, J. N., Ikeda, S.-I., Merlini, G., Saraiva, M. J. M., & Westermark, P. (2012) · Amyloid · doi:10.3109/13506129.2012.734345 · Cited by 311
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
Gervais, F., Paquette, J., Morissette, C., Krzywkowski, P., Yu, M., Azzi, M., Lacombe, D., Kong, X., Aman, A., Laurin, J., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.015 · Cited by 307
Ladiwala, A. R. A., Lin, J. C., Bale, S. S., Marcelino-Cruz, A. M., Bhattacharya, M., Dordick, J. S., & Tessier, P. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133108 · Cited by 297
Walsh, D. M., Thulin, E., Minogue, A. M., Gustavsson, N., Pang, E., Teplow, D. B., & Linse, S. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06862.x · Cited by 284
Meng, F., Abedini, A., Plesner, A., Verchere, C. B., & Raleigh, D. P. (2010) · Biochemistry · doi:10.1021/bi100939a · Cited by 282
Self-citationSmall-molecule aggregates inhibit amyloid polymerization
Feng, B. Y., Toyama, B. H., Wille, H., Colby, D. W., Collins, S. R., May, B. C. H., Prusiner, S. B., Weissman, J., & Shoichet, B. K. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.65 · Cited by 260
Hyung, S.-J., DeToma, A. S., Brender, J. R., Lee, S., Vivekanandan, S., Kochi, A., Choi, J.-S., Ramamoorthy, A., Ruotolo, B. T., & Lim, M. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220326110 · Cited by 238
Porat, Y., Mazor, Y., Efrat, S., & Gazit, E. (2004) · Biochemistry · doi:10.1021/bi048582a · Cited by 226
Dupuis, N. F., Wu, C., Shea, J.-E., & Bowers, M. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903814q · Cited by 215
Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Aβ oligomerization
de Felice, F. G., Vieira, M. N. N., Saraiva, L. M., Figueroa‐Villar, J. D., Garcia‐Abreu, J., Liu, R., Chang, L., Klein, W. L., & Ferreira, S. T. (2004) · The FASEB Journal · doi:10.1096/fj.04-1764com · Cited by 194
Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice
McKee, A. C., Carreras, I., Hossain, L., Ryu, H., Klein, W. L., Oddo, S., LaFerla, F. M., Jenkins, B. G., Kowall, N. W., & Dedeoglu, A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.095 · Cited by 194
Young, L. M., Cao, P., Raleigh, D. P., Ashcroft, A. E., & Radford, S. E. (2014) · Journal of the American Chemical Society · doi:10.1021/ja406831n · Cited by 190
Self-citationGrimster, N. P., Connelly, S., Baranczak, A., Dong, J., Krasnova, L. B., Sharpless, K. B., Powers, E. T., Wilson, I. A., & Kelly, J. W. (2013) · Journal of the American Chemical Society · doi:10.1021/ja311729d · Cited by 186
Turnell, W. G., & Finch, J. T. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90532-o · Cited by 179
Wang, W., Kitova, E. N., & Klassen, J. S. (2003) · Analytical Chemistry · doi:10.1021/ac034300l · Cited by 177
Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses
Connelly, S., Choi, S., Johnson, S. M., Kelly, J. W., & Wilson, I. A. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.12.009 · Cited by 176
Agdeppa, E. D., Kepe, V, Petri, A., Satyamurthy, N., Liu, J., Huang, S.-C., Small, G. W., Cole, G. M., & Barrio, J. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00907-7 · Cited by 172
Meier, J. J., Kayed, R., Lin, C.-Y., Gurlo, T., Haataja, L., Jayasinghe, S., Langen, R., Glabe, C. G., & Butler, P. C. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00082.2006 · Cited by 166
Ferreira, N., Saraiva, M. J., & Almeida, M. R. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.06.030 · Cited by 164
Sun, J., Kitova, E. N., Wang, W., & Klassen, J. S. (2006) · Analytical Chemistry · doi:10.1021/ac0522005 · Cited by 160
Scherzer‐Attali, R., Pellarin, R., Convertino, M., Frydman‐Marom, A., Egoz-Matia, N., Peled, S., Levy‐Sakin, M., Shalev, D. E., Caflisch, A., Gazit, E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011101 · Cited by 159
Nilsson, M. R., & Raleigh, D. P. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3286 · Cited by 150
Self-citationHudson, S. A., Ecroyd, H. W., Dehle, F. C., Musgrave, I., & Carver, J. A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.031 · Cited by 141
Engel, M. F. M., vandenAkker, C. C., Schleeger, M., Velikov, K. P., Koenderink, G. H., & Bonn, M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3031664 · Cited by 137
Analysis of the Inhibition and Remodeling of Islet Amyloid Polypeptide Amyloid Fibers by Flavanols
Cao, P., & Raleigh, D. P. (2012) · Biochemistry · doi:10.1021/bi2015162 · Cited by 135
Self-citationDiversity screening versus focussed screening in drug discovery
Valler, M. J., & Green, D. V. S. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01517-8 · Cited by 130
Alzhemed: A Potential Treatment for Alzheimers Disease
Aisen, P. S. S., Gauthier, S. G., Vellas, B. J., Briand, R., Saumier, D., Laurin, J., & Garceau, D. (2007) · Current Alzheimer Research · doi:10.2174/156720507781788882 · Cited by 128
Kim, Y., Randolph, T. W., Manning, M. C., Stevens, F. J., & Carpenter, J. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212540200 · Cited by 126
Nilsson, M. R., Driscoll, M., & Raleigh, D. P. (2002) · Protein Science · doi:10.1110/ps.48702 · Cited by 124
Self-citationAbedini, A., & Raleigh, D. P. (2005) · Organic Letters · doi:10.1021/ol047480+ · Cited by 114
Self-citationLigand binding to distinct states diverts aggregation of an amyloid-forming protein
Woods, L. A., Platt, G. W., Hellewell, A. L., Hewitt, E. W., Homans, S. W., Ashcroft, A. E., & Radford, S. E. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.635 · Cited by 113
Self-citationDeamidation Accelerates Amyloid Formation and Alters Amylin Fiber Structure
Dunkelberger, E. B., Buchanan, L. E., Marek, P., Cao, P., Raleigh, D. P., & Zanni, M. T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3039486 · Cited by 107
Self-citationPlatt, G. W., Routledge, K. E., Homans, S. W., & Radford, S. E. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.092 · Cited by 98
Self-citationHemin and related porphyrins inhibit β‐amyloid aggregation
Howlett, D., Cutler, P., Heales, S., & Camilleri, P. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01290-8 · Cited by 95
Marek, P., Woys, A. M., Sutton, K., Zanni, M. T., & Raleigh, D. P. (2010) · Organic Letters · doi:10.1021/ol101981b · Cited by 86
Self-citationSulfonated dyes attenuate the toxic effects of β-amyloid in a structure-specific fashion
Pollack, S. J., Sadler, I. I. J., Hawtin, S. R., Tailor, V. J., & Shearman, M. S. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11939-t · Cited by 82
Abedini, A., Singh, G., & Raleigh, D. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.11.029 · Cited by 78
Self-citationSuppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid
Aitken, J. F., Loomes, K. M., Konarkowska, B., & Cooper, G. J. S. (2003) · Biochemical Journal · doi:10.1042/bj20030422 · Cited by 76
Proteins behaving badly: emerging technologies in profiling biopharmaceutical aggregation
Hamrang, Z., Rattray, N. J. W., & Pluen, A. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.05.004 · Cited by 75
Amyloid in the islets of Langerhans: Thoughts and some historical aspects
Westermark, P. (2011) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2011.573884 · Cited by 62
Meng, F., Abedini, A., Plesner, A., Middleton, C. T., Potter, K. J., Zanni, M. T., Verchere, C. B., & Raleigh, D. P. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.001 · Cited by 53
Self-citationHarroun, T. A., Bradshaw, J. P., & Ashley, R. H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02972-6 · Cited by 50
Roterman, I., KrUl, M., Nowak, M., Konieczny, L., Rybarska, J., Stopa, B., Piekarska, B., & Zemanek, G. (2001) · PubMed · Cited by 49
Explicit Solvent Molecular Dynamics Simulations of Aβ Peptide Interacting with Ibuprofen Ligands
Lockhart, C., Kim, S. W., & Klimov, D. K. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp306208n · Cited by 37
Sun, N., Sun, J., Kitova, E. N., & Klassen, J. S. (2009) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2009.02.024 · Cited by 36
Monomeric α-Synuclein Binds Congo Red Micelles in a Disordered Manner
Maltsev, A. S., Grishaev, A., & Bax, A. (2011) · Biochemistry · doi:10.1021/bi201435d · Cited by 33
Meng, F., & Raleigh, D. P. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.12.028 · Cited by 21
Self-citationKamihira-Ishijima, M., Nakazawa, H., Kira, A., Naito, A., & Nakayama, T. (2012) · Biochemistry · doi:10.1021/bi3012274 · Cited by 19
Monitoring oligomer formation from self-aggregating amylin peptides using ESI-IMS-MS
Young, L. M., Ndlovu, H., Knapman, T. W., Harris, S. A., Radford, S. E., & Ashcroft, A. E. (2013) · International Journal for Ion Mobility Spectrometry · doi:10.1007/s12127-012-0115-z · Cited by 18
Self-citation
Cited by
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Zheng, J., Fan, R., Wu, H., Yao, H., Yan, Y., Liu, J., Ran, L., Sun, Z., Yi, L., Dang, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09601-3 · Cited by 414
Implications of peptide assemblies in amyloid diseases
Ke, P. C., Sani, M.-A., Ding, F., Kakinen, A., Javed, I., Separovic, F., Davis, T. P., & Mezzenga, R. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00372b · Cited by 338
Green Tea Extracts EGCG and EGC Display Distinct Mechanisms in Disrupting Aβ42 Protofibril
Zhan, C., Chen, Y., Tang, Y., & Wei, G. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00277 · Cited by 115
Unique insights to intrinsically disordered proteins provided by ion mobility mass spectrometry
Stuchfield, D., & Barran, P. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.01.007 · Cited by 72
Metadata
- Authors
- Young, L. M., Saunders, J. C., Mahood, R. A., Revill, C. H., Foster, R. J., Tu, L.-H., Raleigh, D. P., Radford, S. E., & Ashcroft, A. E.
- Venue
- Nature Chemistry
- Published
- 2014-12-08
- Volume
- 7
- Issue
- 1
- Pages
- 73-81
- ISSN
- 1755-4330 (ISSN-L)
- 1755-4349
- OpenAlex
- W2068834560
- Cited by
- 281
- References
- 64
- FWCI
- 11.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.